Axsome Therapeutics Inc (AXSM)

[georgejjl]

NEW PATENT

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11,419,867.PN.&OS=PN/11,419,867&RS=PN/11,419,867

United States Patent 11,419,867
Tabuteau August 23, 2022
Bupropion as a modulator of drug activity

Abstract
Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Inventors: Tabuteau; Herriot (New York, NY)

Good luck and GOD bless,